# Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and-bioavailability-and-labeling-documentation/b27b2c8a-0cb8-4775-aba0-e2a39c06fd48

> FDA guidance document: Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation. Issue date: April 05, 2018. Get complete insights and analysis.

---

## Details

- Title: Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-04-05
- Last Changed: 2021-10-04
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-2817">FDA-2016-D-2817</a>

## Related Documents

- [Quality Attribute Considerations for Chewable Tablets Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/quality-attribute-considerations-for-chewable-tablets-guidance-for-industry/04e1f98a-29f4-4cc9-a0ab-4017b9877ce9)
- [Environmental Assessment: Questions and Answers Regarding Drugs With Estrogenic, Androgenic, or Thyroid Activity](https://www.globalkeysolutions.net/guidances/guidance-document/environmental-assessment-questions-and-answers-regarding-drugs-with-estrogenic-androgenic-or-thyroid-activity/4f1defd1-fc55-4b85-a9ba-279954bdd658)
- [Regulatory Classification of Pharmaceutical Co-Crystals](https://www.globalkeysolutions.net/guidances/guidance-document/regulatory-classification-of-pharmaceutical-co-crystals/b288c932-6da7-45b6-b036-5876350c1f0f)